{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:48:39Z","timestamp":1781344119927,"version":"3.54.1"},"reference-count":47,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T00:00:00Z","timestamp":1343001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>Recent or continued immobility is a significant risk factor for venous thromboembolism (VTE) in acutely ill medical patients. Patients may benefit from thromboprophylaxis; however, its optimal duration remains unclear. The Extended Clinical Prophylaxis in Acutely Ill Medical Patients (EXCLAIM) study was the first trial to systematically investigate how the degree of immobilization relates to the risk of developing VTE. EXCLAIM offers insights into the duration of VTE risk associated with reduced mobility and helps identify which patients would benefit most from extended-duration thromboprophylaxis. Further recent studies suggest that extended-duration thromboprophylaxis may be in order in certain high-risk patients to protect the patients from the risk of VTE events occurring, particularly in the posthospitalization period. Baseline d-dimer data and level of mobility could be included in risk assessment. Physicians are recommended to consider the use of extended-duration thromboprophylaxis based on individual risk assessment management (RAM) and balance of benefit and harm.<\/jats:p>","DOI":"10.1177\/1076029612452781","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T21:43:58Z","timestamp":1343079838000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Relevance of Immobility and Importance of Risk Assessment Management for Medically Ill Patients"],"prefix":"10.1177","volume":"19","author":[{"given":"Russell D.","family":"Hull","sequence":"first","affiliation":[{"name":"Thrombosis Research Unit, University of Calgary, Foothills Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"bibr1-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0656"},{"key":"bibr2-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60835-5"},{"key":"bibr3-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.05.006"},{"key":"bibr4-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.10.014"},{"key":"bibr5-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1159\/000083845"},{"key":"bibr6-1076029612452781","unstructured":"Virchow R. Gesammalte abhandlungen zur wissenschaftlichen. Frankfurt, Germany: Medinger Sohn and Son; 1856:219\u2013732."},{"key":"bibr7-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2297"},{"key":"bibr8-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2404"},{"key":"bibr9-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.132S"},{"key":"bibr10-1076029612452781","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-10-200111200-00006"},{"key":"bibr11-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05249-1"},{"key":"bibr12-1076029612452781","first-page":"CD004318","volume":"1","author":"Rasmussen MS","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr13-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.809"},{"key":"bibr14-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2296"},{"issue":"4","key":"bibr15-1076029612452781","first-page":"592","volume":"88","author":"Oger E","year":"2002","journal-title":"Thromb Haemost"},{"key":"bibr16-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01012.x"},{"key":"bibr17-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-12-0827"},{"key":"bibr18-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1944"},{"key":"bibr19-1076029612452781","author":"Ageno W","year":"2011","journal-title":"Intern Emerg Med"},{"issue":"2","key":"bibr20-1076029612452781","first-page":"49","volume":"26","author":"Lechler E","year":"1996","journal-title":"Haemostasis"},{"key":"bibr21-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.189"},{"key":"bibr22-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000138928.83266.24"},{"key":"bibr23-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38733.466748.7C"},{"key":"bibr24-1076029612452781","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-153-1-201007060-00004"},{"key":"bibr25-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-04-0236"},{"key":"bibr26-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-011-0549-x"},{"key":"bibr27-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110899"},{"key":"bibr28-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411103"},{"key":"bibr29-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-006-7732-5"},{"key":"bibr30-1076029612452781","unstructured":"Cohen AT. on behalf of the MAGELLAN Steering Committee and Investigators. Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. Accessed February 6, 2012, http:\/\/my.americanheart.org\/idc\/groups\/ahamah-public\/@wcm\/@sop\/@scon\/documents\/downloadable\/ucm_425442.pdf. Accessed February 6, 2012."},{"key":"bibr31-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02984.x"},{"issue":"2","key":"bibr32-1076029612452781","first-page":"101","volume":"25","author":"Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phl\u00e9bologie. Prevention and treatment of venous thromboembolism","year":"2006","journal-title":"Int Angiol"},{"key":"bibr33-1076029612452781","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-9-201111010-00011"},{"key":"bibr34-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1283"},{"key":"bibr35-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3214"},{"key":"bibr36-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02268.x"},{"key":"bibr37-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01453-5"},{"key":"bibr38-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(98)00018-8"},{"key":"bibr39-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655901"},{"key":"bibr40-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609053351002"},{"key":"bibr41-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615775"},{"key":"bibr42-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.11.1362"},{"key":"bibr43-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.11.1337"},{"key":"bibr44-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613749"},{"key":"bibr45-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.542.542"},{"key":"bibr46-1076029612452781","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.82.82"},{"issue":"21","key":"bibr47-1076029612452781","volume":"118","author":"Hull RD","year":"2011","journal-title":"Blood"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1076029612452781","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1076029612452781","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1076029612452781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:04:36Z","timestamp":1777385076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1076029612452781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,23]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1177\/1076029612452781"],"URL":"https:\/\/doi.org\/10.1177\/1076029612452781","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,23]]}}}